While relatively young, John Burbank�� firm, Passport Capital, has been quite successful on the strength of its fundamentals-focused stock picking and more exotic plays based on global macro conditions. Since Burbank launched Passport in 2000, he has grown assets to $3.3 billion under management, delivered an annualized 23 percent return to investors, and, this month, become GuruFocus��newest Guru.
In his pre-hedge fund past, Burbank was a consultant to Roger Richter of JMG Triton Offshore Ltd. and director of research at ValueVest Management. His investing career began just before the late-��0s Asian crisis, where he learned valuable lessons that helped him avoid the dot-com debacle several years later. He earned a B.A. from Duke University and an MBA from Stanford Graduate School of Business.
Currently Burbank has both an equity portfolio and some intriguing irons in the fire elsewhere, but his 12-year history with Passport has been eventful as well.
In Passport�� first year of operation, it shunned the tech craze and shorted high-flying technology stocks. For the three years the S&P 500 reeled from the backlash of the overvalued stocks with returns in the negative numbers, Burbank�� flagship Global Strategy fund returned 36% in 2000, 7% in 2001 and 22.1% in 2002.
Best Oil Companies To Own For 2015: Cyan Inc (CYNI)
Cyan, Inc., incorporated on October 25, 2006, has carrier-grade networking solutions that transform legacy networks into open, high-performance networks. The Company�� solutions include high-capacity, multi-layer switching and transport platforms, as well as a carrier-grade software-defined networking platform and applications. The Company�� solutions enable network operators to virtualize their networks, accelerate service delivery. The Company has designed its solutions to provide a range of applications, including business Ethernet, Wireless and broadband support services and cloud connectivity. The Company also offer high-capacity, multi-layer switching and transport platforms, known as its Cyan Z-Series, that have been designed to support the multiple concurrent technologies used in regional and metro networks, including both Ethernet-based services, as well as optical services.
The Company�� Z-Series platforms have been designed to transport traffic over network layer, utilizing both electrical and optical domains, to enable network operators to maximize network capacity at the lowest cost per bit. The Company�� customers range from service providers to high-performance data center and large, private network operators.
Advisors' Opinion:- [By Lauren Pollock]
Among the companies with shares expected to actively trade in Tuesday’s session are Cyan Inc.(CYNI), Neurocrine Biosciences Inc.(NBIX) and SandRidge Energy Inc.(SD)
Top 5 Tech Companies To Buy Right Now: MagnaChip Semiconductor Corporation (MX)
MagnaChip Semiconductor Corporation designs and manufactures analog and mixed-signal semiconductor products for high-volume consumer applications. It operates in three segments: Display Solutions, Power Solutions, and Semiconductor Manufacturing Services. The Display Solutions segment offers source and gate drivers, and timing controllers that cover a range of flat panel displays used in liquid crystal displays (LCDs), light emitting diodes (LEDs), 3D and organic light emitting diode televisions and displays, notebooks, and mobile communications and entertainment devices. The Power Solutions segment develop, manufactures, and markets power management solutions, including metal oxide semiconductor field effect transistors, power modules, analog switches, LED drivers, DC-DC converters, voice coil motor drivers, and linear regulators. This segment offers its products for a range of devices, including LCD, LED, 3D televisions, smartphones, mobile phones, desktop PCs, notebooks , tablet PCs, and other consumer electronics, as well as for industrial applications, such as power suppliers, LED lighting, and home appliances. The Semiconductor Manufacturing Services segment manufactures various products comprising display drivers, LED drivers, audio encoding and decoding devices, microcontrollers, touch screen controllers, RF switches, park distance control sensors for automotives, electronic tag memories, and power management semiconductors. This segment offers semiconductor manufacturing services to fabless analog and mixed-signal semiconductor companies. MagnaChip Semiconductor Corporation provides its products and services to consumer electronics OEMs, subsystem designers, and contract manufacturers through a direct sales force, as well as through a network of authorized agents and distributors in the United States, Korea, Taiwan, China, Japan, Hong Kong, and Macau. The company is headquartered in Seoul, South Korea.
Advisors' Opinion:- [By Brian Pacampara]
Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, consumer gadget chip maker MagnaChip Semiconductor (NYSE: MX ) has earned a coveted five-star ranking.
- [By Wallace Witkowski]
Shares of MagnaChip Semiconductor Corp. (MX) �fell 13% to $12.50 on moderate volume after the company said it incorrectly stated revenue and has to restate its financial statements going back to 2011. Also, the company withdrew its guidance for the fourth quarter.
Top 5 Tech Companies To Buy Right Now: Lexmark International Inc.(LXK)
Lexmark International, Inc., together with its subsidiaries, engages in the development, manufacture, and supply of printing, imaging, document workflow, and content management solutions for offices in North and South America, Europe, the Middle East, Africa, Asia, the Pacific Rim, and the Caribbean. It offers monochrome and color laser printers, laser multifunction products, inkjet all-in-one devices, dot matrix printers, and cartridges and other supplies; and services and solutions, including maintenance, consulting, and systems integration, as well as managed print services, such as asset lifecycle management, implementation and decommissioning services, consumables management, optimization services, and utilization management. The company also provides enterprise content management (ECM) software products, including ImageNow document management, document imaging, and workflow suite that allows users to capture, process, and collaborate on important documents and inform ation, protect data integrity throughout its lifecycle, and access precise content; and industry specific workflow solutions for the healthcare, higher education, government, and financial services industries, as well as for back office functions, including accounting, human resources, contracts, and records. Its software modules include Retention Policy Manager to manage the complete lifecycle of content from creation to destruction or disposition; Business Insight, which integrates IBM Cognos to provide industry and business process dashboards, operational and ad-hoc reporting, and report design tools; workflow software that automates processing steps, simplifies work tasks, and provides real-time monitoring; and eForms module, which enables the online entry and collection of raw data in electronic forms that are accessible from Web sites and portals. The company was founded in 1990 and is headquartered in Lexington, Kentucky.
Advisors' Opinion:- [By Rich Duprey]
Printer maker�Lexmark (NYSE: LXK ) announced yesterday its third-quarter dividend of $0.30 per share, the same rate it's paid for the past five quarters after raising the payout 20% from $0.25 per share.
- [By Lee Jackson]
Lexmark International Inc. (NYSE: LXK) is another name that has slowly, but surely, lost its cache as an industry leader. Once one of the premiere names in high-end printers, the company continues to lose market share. It also has very little to offer in terms of innovation and new and exciting products. The stock does pay shareholders a solid 2.9% dividend. The Merrill Lynch price target is $31, and the consensus price target is $31.75. That is far below Friday’s closing price of $41.12.
Top 5 Tech Companies To Buy Right Now: Regulus Therapeutics Inc (RGLS)
Regulus Therapeutics Inc., incorporated on September 5, 2007, is a biopharmaceutical company focused on discovering and developing microRNAs to treat a range of diseases. microRNAs are naturally occurring ribonucleic acid (RNA), molecules that play a critical role in regulating key biological pathways. The Company uses its microRNA product platform to develop chemically modified, single-stranded oligonucleotides that the Company calls anti-miRs. As of December 31, 2012, the Company�� operations included acquiring and in-licensing intellectual property rights, developing its microRNA, undertaking basic research around microRNA targets and conducting preclinical studies for its initial programs.
The Company is developing RG-101 for the treatment of HCV and is advancing other microRNA therapeutics toward clinical development in several areas, including oncology, fibrosis and metabolic diseases. The Company intends to focus its resources on product opportunities in therapeutic areas where development and commercialization activities are appropriate for its size and financial resources, which the Company anticipates will include niche indications and orphan diseases.
The Company competes with Groove Biopharma, Inc., miRagen Therapeutics, Inc., Mirna Therapeutics, Inc., and Santaris Pharma A/S.
Advisors' Opinion:- [By Brian Orelli]
Partners like this investment idea
When Regulus Therapeutics (NASDAQ: RGLS ) went public last year, investors weren't the only ones buying the share offering; Regulus' partners and founders clearly thought it was a good investment idea, because they bought more shares. Lots of them. AstraZeneca, Biogen Idec, Sanofi, GlaxoSmithKline�and Isis combined to purchase more than 70% of the shares that raised nearly $81 million for the biotech. - [By Sean Williams]
A blast to the past
It's occasionally very difficult to value biotech stocks, because of the wide range of outcomes possible given their pipelines. Other times, as in the case with Regulus Pharmaceuticals (NASDAQ: RGLS ) , I bang my head against a table and wonder what the heck investors are thinking. - [By Sean Williams]
Regulus Therapeutics (NASDAQ: RGLS )
Since presenting at the Deutsche Bank Healthcare Conference two weeks ago, shares of Regulus Therapeutics have been absolutely on fire. A mixture of ASCO and IPO fever have revived the love for newer issues, and having big name pharmaceutical companies gobbling up a majority of its IPO'd shares certainly helps its cause.
No comments:
Post a Comment